Skip to main content
TipRanks
Go Ultimate75% OFF

Vertex Pharmaceuticals (VX1) Q1 2026 Earnings Report

23 Followers

DE:VX1 Q1 2026 EPS Results

Actual EPS
EUR 4.06
Consensus EPS
EUR 3.85
Beat/Miss
Beat by +EUR 0.21
One Year Ago EPS
EUR 3.68

DE:VX1 Q1 2026 Revenue Results

Actual Revenue
EUR 2.73B
Expected Revenue
EUR 2.72B
Beat/Miss
Beat by +EUR 16.51M
YoY Revenue Growth
+9.70%

Earnings Announcement Details

Quarter
Q1 2026
Date
05/04/2026
Time
After Close
Conference Call
Monday, May 4, 2026
DE:VX1 Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q1 2026 Earnings Call Audio

DE:VX1 Q1 2026 Earnings Call
0:00 / 0:00

Q1 2026 Earnings Slide Deck

Q1 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:VX1 Earnings History

DE:VX1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 09, 20272026 (Q4)3.81-4.56――
Nov 02, 20262026 (Q3)4.374.324.35-0.83% (-0.04)
Aug 03, 20262026 (Q2)4.304.294.14.65% (+0.19)
May 04, 20262026 (Q1)3.854.063.6810.10% (+0.37)
Feb 12, 20262025 (Q4)4.644.563.6126.38% (+0.95)
Nov 03, 20252025 (Q3)4.154.353.979.59% (+0.38)
Aug 06, 20252025 (Q2)3.894.10-11.64135.23% (+15.74)
May 05, 20252025 (Q1)3.923.684.32-14.71% (-0.64)
Feb 10, 20252024 (Q4)3.643.613.81-5.24% (-0.20)
Nov 04, 20242024 (Q3)3.703.973.77.35% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed